• About us
  • Membership
  • Contact us
  • Sat September 27, 2025

  • Home
  • Society
  • Economy
  • Politics
  • Sports
  • Culture
  • International
  • Multimedia
  • Tourism

Spikogen vaccine licensed for emergency use

Total:2

  • Negotiations underway to export Spikogen vaccine 2022-01-18 18:05

    Negotiations underway to export Spikogen vaccine

    TEHRAN – Negotiations are underway with other countries to export the Iranian-Australian Spikogen vaccine, but the main priority is to meet domestic needs, Khashayar Roshanzamir, technical officer of clinical study of Spikogen vaccine, has said.

  • Spikogen vaccine licensed for emergency use 2021-10-08 17:22

    Spikogen vaccine licensed for emergency use

    TEHRAN – The Food and Drug Administration has issued an emergency permit for the Iranian-Australian Spikogen vaccine, IRNA reported on Thursday.

All Pages

Latest

  • Esteghlal, Shams Azar settle for a draw

  • 15155

  • What’s in Tehran art galleries

  • IAF cinematheque reviews “The Best Years of a Life”

  • Asghar Farhadi starts shooting 10th feature film “Parallel Tales” in Paris

  • Russia and China are trying to delay the snapback

  • Renewed US military presence in Afghanistan endangers regional peace: Tehran

  • Eastward bound: How US is driving West Asian states into China and Russia’s embrace 

  • 'Well done, Iran' ceremony honors Armed Forces after war with Israel 

  • Intelligence ministry releases Israeli nuclear, military secrets in IRIB documentary

  • Iranian women’s role in 12-day war with Israel

  • Last chance for diplomacy 

  • Protests and walkouts eclipse Netanyahu’s UN appearance

  • Iran and China deepen cooperation under Global Governance Initiative

  • Lebanon PM vs. the Resistance: Who stands to gain?

Desktop version Mobile version
Top
  • About us
  • Membership
  • Contact us
  • Home
  • Society
  • Economy
  • Politics
  • Sports
  • Culture
  • International
  • Multimedia
  • Tourism

All Content by Mehr News Agency is licensed under a Creative Commons Attribution 4.0 International License.

Developed by: Nastooh Designed by: Pixel Studio